Your session is about to expire
← Back to Search
Technology-Based Program for Pregnancy (BETTER Trial)
N/A
Waitlist Available
Led By Caitlin E Martin, MD, MPH
Research Sponsored by Virginia Commonwealth University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 2 weeks of completing the intervention
Awards & highlights
BETTER Trial Summary
This trial will test if a new educational technology-based program and brochure can help pregnant and parenting women receiving medication for Opioid Use Disorder (OUD) with common challenges they may face.
Who is the study for?
This trial is for pregnant women over 18 with Opioid Use Disorder who are within their first 34 weeks of pregnancy and have visited the OB MOTIVATE clinic in the last 10 weeks. They must be on medication-assisted treatment for OUD. Women planning adoption or those with serious cognitive issues or language barriers that prevent informed consent cannot participate.Check my eligibility
What is being tested?
The study is evaluating a new educational technology-based program alongside a brochure, designed to support pregnant and parenting women dealing with OUD. It focuses on educating about post-pregnancy transition, neonatal withdrawal syndromes, and child welfare system interactions.See study design
What are the potential side effects?
Since this trial involves an educational program rather than medical treatments, traditional side effects are not applicable. However, participants may experience emotional or psychological responses to the content provided.
BETTER Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline to within 2 weeks of completing the intervention, up to 5 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to within 2 weeks of completing the intervention, up to 5 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Acceptability of the intervention
Feasibility of the intervention
Secondary outcome measures
Change in parental competence
Change in perceived competence
BETTER Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Technology-based programExperimental Treatment1 Intervention
Group II: BrochureActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
technology-based program
2022
N/A
~40
Find a Location
Who is running the clinical trial?
Virginia Commonwealth UniversityLead Sponsor
698 Previous Clinical Trials
22,884,964 Total Patients Enrolled
Caitlin E Martin, MD, MPHPrincipal InvestigatorVirginia Commonwealth University
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Brochure
- Group 2: Technology-based program
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What is the current participation quota for this research program?
"Affirmative. The information hosted on clinicaltrials.gov reveals that this medical trial, first posted in February 2nd 2022, is actively accepting participants at the moment. Aspiring patients should note that only 30 individuals will be recruited from a solitary site."
Answered by AI
Are there any unoccupied slots for participants in this exploration?
"According to clinicaltrials.gov, this research is accruing participants at the present time. It was advertised on February 2nd 2022 and last updated on the same day."
Answered by AI
Share this study with friends
Copy Link
Messenger